|
Volumn 127, Issue 1, 2012, Pages 18-21
|
Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer
|
Author keywords
Cost; Venous thromboembolism prevention
|
Indexed keywords
ENOXAPARIN;
ABDOMINAL SURGERY;
ADULT;
AGED;
ARTICLE;
CANCER SURGERY;
FEMALE;
GYNECOLOGIC CANCER;
HEALTH CARE COST;
HOSPITAL DISCHARGE;
HUMAN;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
OUTPATIENT CARE;
OVARY CANCER;
PELVIS SURGERY;
PRESCRIPTION;
PRIORITY JOURNAL;
THROMBOSIS PREVENTION;
TREATMENT DURATION;
UTERINE CERVIX CANCER;
UTERUS CANCER;
VAGINA CANCER;
VENOUS THROMBOEMBOLISM;
VULVA CANCER;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
COST-BENEFIT ANALYSIS;
ENOXAPARIN;
FEMALE;
GENITAL NEOPLASMS, FEMALE;
GYNECOLOGIC SURGICAL PROCEDURES;
HEALTH CARE COSTS;
HEALTH EXPENDITURES;
HUMANS;
INSURANCE COVERAGE;
MIDDLE AGED;
PRESCRIPTION FEES;
UNITED STATES;
VENOUS THROMBOEMBOLISM;
YOUNG ADULT;
|
EID: 84865682437
PISSN: 00908258
EISSN: 10956859
Source Type: Journal
DOI: 10.1016/j.ygyno.2012.07.096 Document Type: Article |
Times cited : (13)
|
References (9)
|